ALS Drug Needs More Evidence, FDA Advisors Say But vote was close and panelists remain hopeful about AMX0035 Mar 31, 2022
Another Oral Testosterone Undecanoate OK'd for Hypogonadism FDA approval of Tlando follows in the footsteps of Jatenzo Mar 29, 2022
Novel Fixed-Dose Immunotherapy Combo Wins FDA Approval Nivolumab plus relatlimab doubled progression-free survival in unresectable melanoma Mar 21, 2022
Medicare Claws Back Money for Dubious Birth-Tissue Stem Cell Shots Government seeks to recoup more than 2 years of payments for unproven treatments Mar 16, 2022
Meet the Primary Care Doc Who Wants the World to Go Back to Normal Lucy McBride, MD, has become a loud, controversial voice in the debate on COVID precautions Mar 15, 2022
First Generic OK'd for Popular Asthma, COPD Inhaler FDA approves Mylan's Symbicort copy, reflecting agency's commitment to "increase competition" Mar 15, 2022
FDA Warns on Using Surgical Device for Aesthetic Skin Procedures Agency details potentially life-threatening adverse events with plasma-generating device Mar 14, 2022
FDA OKs PARP Inhibitor as Adjuvant Therapy in Early Breast Cancer Olaparib (Lynparza) approved for high-risk patients with germline BRCA mutations Mar 14, 2022
FDA Begins Releasing Pfizer COVID Vax Documents Court-ordered release runs risk of "cherry picking and taking things out of context" Mar 07, 2022
Dr. Bronner's Offering Its Workers Psychedelic Therapy Coverage Soap company to cover ketamine-assisted therapy for employees with new industry nonprofit Mar 01, 2022
Thumbs Down for IV Tramadol, FDA Advisers Say Delayed onset of pain relief remains a concern Feb 16, 2022
FDA OKs 180-Day Implantable Continuous Glucose Monitor Senseonics' Eversense E3 System approved for adults with diabetes Feb 11, 2022
FDA Warns of Strangulation Risk for Kids on Feeding Tubes Two toddlers died after being found with enteral feeding systems' tubing around their necks Feb 09, 2022
FDA Concerned About Safety of Lymphoma Drug Hint of excess mortality in trial of umbralisib/ublituximab prompts public notice Feb 03, 2022
FDA Approves First Generic of Restasis for Dry Eye A new option for those affected by keratoconjunctivitis sicca Feb 02, 2022
Another COVID Vaccine Garners Full FDA Approval Moderna's Spikevax approved for adults ages 18 and up Jan 31, 2022
Are We Equipped to Care for People With Intellectual, Developmental Disabilities? Low accreditation standards are contributing to health disparities Jan 20, 2022
FDA OKs Two Oral JAK Inhibitors for Refractory Atopic Dermatitis Once-daily abrocitinib and upadacitinib join topical ruxolitinib in expanding AD market Jan 18, 2022
Growing Controversy Over 'Skinny' Labeling for Generic Drugs What's at stake in legal battles over patent-avoiding approval pathway for generics Jan 17, 2022
(When) to Boost or Not to Boost, That Is the Question Countless complex questions remain Jan 13, 2022
Why Are Physicians Silent About Outrageous Drug Prices? Milton Packer wonders why physicians are struggling to get their priorities straight Jan 12, 2022
Nose or Throat: What’s Best for a COVID Test? Early data support saliva testing, but it might be too early to tell Jan 06, 2022
FDA OKs Endogenous Cushing's Syndrome Treatment Recorlev reduced and normalized cortisol levels in clinical studies Jan 04, 2022
Alzheimer's Drugs Race to FDA After aducanumab, drug companies pivot to use the accelerated approval pathway Jan 01, 2022
What Happened to the Novavax Vaccine? As mRNA vaccines saturate the U.S. market, is there room for another? Jan 01, 2022
'Pending Wave' of Nurse Substance Use Problems? Signs point to deepening issue with alcohol, drugs as nurses battle through the pandemic Dec 30, 2021
Doctor Submits Fluvoxamine EUA Application to FDA Group of physician-scientists believes data support authorization for treating COVID-19 Dec 29, 2021
IL-13 Inhibitor Approved for Adults With Atopic Dermatitis Significantly greater lesion clearance with tralokinumab in placebo-controlled studies Dec 28, 2021
FDA Approves First Long-Acting Injectable to Prevent HIV Infection Apretude is administered every 2 months versus a daily pill Dec 21, 2021
Novel Myasthenia Gravis Treatment Wins FDA Nod Efgartigimod is the first approved FcRn blocker Dec 20, 2021
Medical Translation Sacrifices Accuracy for Understanding In health facilities and the pharmaceutical industry, this has consequences for patients Dec 17, 2021
FDA Relaxes Restrictions on Abortion Pill Federal government permanently removes requirements that patients pick up mifepristone in person Dec 17, 2021
U.S. Dragging Its Feet on Biosimilar Approvals, Pharmacist Says Introduction of biosimilars falling behind that of other countries Dec 09, 2021
The ASHP Wants to Stop White Bagging on Prescription Drugs This practice "jeopardizes patient care," says ASHP official Dec 07, 2021
Getting COVID Antiviral Pills Into Patients' Hands Here's how to foster equal access to two treatments that may soon be authorized Dec 01, 2021
Is Psychedelic Research Funding Starting to Shift? Once the province of philanthropy, industry and government sources show interest Nov 24, 2021
FDA OKs First Drug for Most Common Form of Dwarfism Mixed reactions follow new treatment for children 5 and up with open growth plates Nov 19, 2021
Buprenorphine Misuse: What's the Reality? New study highlights need to expand access to buprenorphine for OUD Nov 18, 2021
Preterm Birth Drug Tied to Cancer Risk in Those Exposed in Utero Mothers who took 17-OHPC for miscarriage in the 1950s and 1960s had offspring at greater risk Nov 12, 2021
Experts Blow Whistle on Alleged COVID Vaccine Whistleblower Claims Allegations described as "vague kind of hand waving" Nov 05, 2021